A detailed history of Pinnacle Wealth Planning Services, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Pinnacle Wealth Planning Services, Inc. holds 19,852 shares of AZN stock, worth $1.49 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
19,852
Previous 18,948 4.77%
Holding current value
$1.49 Million
Previous $1.28 Million 20.65%
% of portfolio
0.22%
Previous 0.19%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$66.81 - $80.83 $60,396 - $73,070
904 Added 4.77%
19,852 $1.55 Million
Q1 2024

May 09, 2024

BUY
$61.03 - $69.57 $5,797 - $6,609
95 Added 0.5%
18,948 $1.28 Million
Q4 2023

Feb 07, 2024

SELL
$61.89 - $69.28 $2,228 - $2,494
-36 Reduced 0.19%
18,853 $1.27 Million
Q3 2023

Nov 07, 2023

BUY
$64.85 - $71.7 $75,744 - $83,745
1,168 Added 6.59%
18,889 $1.28 Million
Q2 2023

Aug 07, 2023

SELL
$69.91 - $75.81 $98,992 - $107,346
-1,416 Reduced 7.4%
17,721 $1.27 Million
Q4 2022

Feb 13, 2023

BUY
$54.21 - $70.44 $45,373 - $58,958
837 Added 4.57%
19,137 $1.3 Million
Q3 2022

Nov 09, 2022

BUY
$53.02 - $135.75 $102,222 - $261,726
1,928 Added 11.78%
18,300 $1 Million
Q2 2022

Aug 03, 2022

BUY
$59.26 - $71.14 $5,511 - $6,616
93 Added 0.57%
16,372 $1.08 Million
Q1 2022

Apr 20, 2022

BUY
$55.72 - $67.12 $19,557 - $23,559
351 Added 2.2%
16,279 $1.08 Million
Q4 2021

Jan 21, 2022

BUY
$54.02 - $63.83 $2,863 - $3,382
53 Added 0.33%
15,928 $928,000
Q3 2021

Oct 29, 2021

BUY
$55.56 - $60.79 $258,965 - $283,342
4,661 Added 41.56%
15,875 $953,000
Q2 2021

Aug 02, 2021

BUY
$48.42 - $60.18 $116,595 - $144,913
2,408 Added 27.34%
11,214 $671,000
Q1 2021

Apr 29, 2021

BUY
$47.16 - $54.44 $114,881 - $132,615
2,436 Added 38.24%
8,806 $438,000
Q4 2020

Feb 12, 2021

BUY
$48.52 - $58.02 $18,583 - $22,221
383 Added 6.4%
6,370 $318,000
Q3 2020

Nov 03, 2020

SELL
$53.07 - $61.1 $118,452 - $136,375
-2,232 Reduced 27.16%
5,987 $328,000
Q2 2020

Jul 27, 2020

SELL
$43.1 - $55.31 $57,840 - $74,226
-1,342 Reduced 14.04%
8,219 $435,000
Q1 2020

May 11, 2020

BUY
$37.79 - $51.33 $48,031 - $65,240
1,271 Added 15.33%
9,561 $426,000
Q4 2019

Feb 07, 2020

SELL
$42.46 - $50.46 $7,133 - $8,477
-168 Reduced 1.99%
8,290 $413,000
Q3 2019

Oct 31, 2019

BUY
$40.12 - $45.47 $30,089 - $34,102
750 Added 9.73%
8,458 $376,000
Q2 2019

Aug 06, 2019

BUY
$37.28 - $41.68 $57,523 - $64,312
1,543 Added 25.03%
7,708 $319,000
Q1 2019

May 08, 2019

SELL
$35.49 - $43.02 $33,573 - $40,696
-946 Reduced 13.3%
6,165 $249,000
Q4 2018

Mar 01, 2019

SELL
$36.86 - $41.49 $346,963 - $390,545
-9,413 Reduced 56.97%
7,111 $270,000
Q3 2018

Feb 28, 2019

BUY
$34.76 - $39.72 $11,192 - $12,789
322 Added 1.99%
16,524 $654,000
Q2 2018

Feb 28, 2019

SELL
$34.55 - $37.05 $4,491 - $4,816
-130 Reduced 0.8%
16,202 $568,000
Q1 2018

Feb 28, 2019

BUY
$32.97 - $36.63 $442,127 - $491,208
13,410 Added 458.93%
16,332 $572,000
Q4 2017

Feb 12, 2018

BUY
$32.09 - $34.78 $93,766 - $101,627
2,922
2,922 $101,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Pinnacle Wealth Planning Services, Inc. Portfolio

Follow Pinnacle Wealth Planning Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Planning Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Wealth Planning Services, Inc. with notifications on news.